Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 3 Researches
7.3
USERS' SCORE
Medium or Average
Based on 14 Reviews
6.5
Supplement Facts
Serving Size: 1 Vegetable Capsule
Amount Per Serving
%DV
Iron (as iron bisglycinate chelate†)
25 mg
139%
Top Medical Research Studies
9
Magnetic stent-grafts improve healing
We explored how magnetizable stent-grafts can improve healing in carotid artery pseudoaneurysms by investigating their ability to capture blood outgrowth endothelial cells.
In a porcine model, we compared magnetic stent-grafts with standard non-magnetic ones. The results showed that the magnetic stent-grafts not only occluded all nine pseudoaneurysms but also achieved better cell capture and endothelial growth.
Essentially, the magnetic properties enhanced the healing process, leading to less thrombosis compared to non-magnetic counterparts. This innovative approach could reduce complications associated with these medical devices.
In a porcine model, we compared magnetic stent-grafts with standard non-magnetic ones. The results showed that the magnetic stent-grafts not only occluded all nine pseudoaneurysms but also achieved better cell capture and endothelial growth.
Essentially, the magnetic properties enhanced the healing process, leading to less thrombosis compared to non-magnetic counterparts. This innovative approach could reduce complications associated with these medical devices.
Read More
9
ESA and iron enhance surgery outcomes
We aimed to understand how preoperative treatments like erythropoietin-stimulating agents (ESAs) and intravenous (IV) iron influence the risk of blood clots in surgical patients dealing with anaemia.
In our investigation, we found that patients who received ESAs—whether accompanied by IV iron or not—had lower risks of serious post-operative complications, including blood clots, compared to those who were given red blood cell transfusions. Specifically, those treated with ESAs without IV iron showed significant reductions in mortality and the occurrence of venous thromboembolic events.
Interestingly, when IV iron was combined with ESAs, it appeared to further enhance outcomes, notably improving survival rates. Our results suggest that combining these treatments might yield benefits for patients undergoing surgery, reflected in higher haemoglobin levels and fewer complications compared to traditional blood transfusions.
In our investigation, we found that patients who received ESAs—whether accompanied by IV iron or not—had lower risks of serious post-operative complications, including blood clots, compared to those who were given red blood cell transfusions. Specifically, those treated with ESAs without IV iron showed significant reductions in mortality and the occurrence of venous thromboembolic events.
Interestingly, when IV iron was combined with ESAs, it appeared to further enhance outcomes, notably improving survival rates. Our results suggest that combining these treatments might yield benefits for patients undergoing surgery, reflected in higher haemoglobin levels and fewer complications compared to traditional blood transfusions.
Read More
4
We explored a 50-year-old woman who came to us with noticeable swelling and pain in her left leg lasting ten days. Upon evaluation, we found that she had deep vein thrombosis (DVT) associated with May-Thurner Syndrome (MTS), where a vein is compressed by an artery. Initially, her blood tests showed normocytic anemia, yet the tests for blood clotting disorders returned normal.
Treatment began with anticoagulation therapy using enoxaparin, coupled with iron supplementation. While iron is typically known for helping with anemia, its specific effect on blood clot resolution in this case remains unclear. Our patient's initial treatments were expanded to include catheter-directed thrombolysis to dissolve the clot, followed by a procedure to relieve venous compression.
We observed significant success in reducing the thrombus burden and restoring blood flow post-stenting. However, we noted that the role of iron supplementation alone in treating the blood clot is ambiguous when combined with other therapies. Thus, while iron is essential for overall health and could play a supportive role, its independent effectiveness against DVT is undetermined in this scenario.
Treatment began with anticoagulation therapy using enoxaparin, coupled with iron supplementation. While iron is typically known for helping with anemia, its specific effect on blood clot resolution in this case remains unclear. Our patient's initial treatments were expanded to include catheter-directed thrombolysis to dissolve the clot, followed by a procedure to relieve venous compression.
We observed significant success in reducing the thrombus burden and restoring blood flow post-stenting. However, we noted that the role of iron supplementation alone in treating the blood clot is ambiguous when combined with other therapies. Thus, while iron is essential for overall health and could play a supportive role, its independent effectiveness against DVT is undetermined in this scenario.
Read More
Most Useful Reviews
9
Symptoms alleviated
4 people found this helpful
I was identified with anaemia and began treatment recently. I noticed that dizziness from the anaemia has disappeared. I'm looking forward to my next blood test, as I feel significantly better overall.
Read More
9
Effective treatment
3 people found this helpful
This iron supplement literally saved me from needing a fourth blood transfusion. My levels were so low that my doctor suggested a transfusion. After taking two pills daily for three months, my hemoglobin rose from 8 to 12, and my iron from 15 to 40! There's no further proof required; it works!
Read More
9
Effective treatment
3 people found this helpful
Helped with anaemia. My spouse's blood test revealed a low haemoglobin of 79. Despite feeling well, the therapist didn’t believe it, but a retest confirmed the low level. After taking Sorbifer Durules for a month, we switched to Iron of the Sun based on positive reviews. We also added vitamin C. After 1.6 months, his haemoglobin rose to 144 without gastrointestinal side effects. It's rewarding to find an affordable and effective solution for health, which is paramount in life.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 3 Researches
7.3
- All Researches
9
ESA and iron enhance surgery outcomes
We aimed to understand how preoperative treatments like erythropoietin-stimulating agents (ESAs) and intravenous (IV) iron influence the risk of blood clots in surgical patients dealing with anaemia.
In our investigation, we found that patients who received ESAs—whether accompanied by IV iron or not—had lower risks of serious post-operative complications, including blood clots, compared to those who were given red blood cell transfusions. Specifically, those treated with ESAs without IV iron showed significant reductions in mortality and the occurrence of venous thromboembolic events.
Interestingly, when IV iron was combined with ESAs, it appeared to further enhance outcomes, notably improving survival rates. Our results suggest that combining these treatments might yield benefits for patients undergoing surgery, reflected in higher haemoglobin levels and fewer complications compared to traditional blood transfusions.
In our investigation, we found that patients who received ESAs—whether accompanied by IV iron or not—had lower risks of serious post-operative complications, including blood clots, compared to those who were given red blood cell transfusions. Specifically, those treated with ESAs without IV iron showed significant reductions in mortality and the occurrence of venous thromboembolic events.
Interestingly, when IV iron was combined with ESAs, it appeared to further enhance outcomes, notably improving survival rates. Our results suggest that combining these treatments might yield benefits for patients undergoing surgery, reflected in higher haemoglobin levels and fewer complications compared to traditional blood transfusions.
Read More
9
Magnetic stent-grafts improve healing
We explored how magnetizable stent-grafts can improve healing in carotid artery pseudoaneurysms by investigating their ability to capture blood outgrowth endothelial cells.
In a porcine model, we compared magnetic stent-grafts with standard non-magnetic ones. The results showed that the magnetic stent-grafts not only occluded all nine pseudoaneurysms but also achieved better cell capture and endothelial growth.
Essentially, the magnetic properties enhanced the healing process, leading to less thrombosis compared to non-magnetic counterparts. This innovative approach could reduce complications associated with these medical devices.
In a porcine model, we compared magnetic stent-grafts with standard non-magnetic ones. The results showed that the magnetic stent-grafts not only occluded all nine pseudoaneurysms but also achieved better cell capture and endothelial growth.
Essentially, the magnetic properties enhanced the healing process, leading to less thrombosis compared to non-magnetic counterparts. This innovative approach could reduce complications associated with these medical devices.
Read More
4
We explored a 50-year-old woman who came to us with noticeable swelling and pain in her left leg lasting ten days. Upon evaluation, we found that she had deep vein thrombosis (DVT) associated with May-Thurner Syndrome (MTS), where a vein is compressed by an artery. Initially, her blood tests showed normocytic anemia, yet the tests for blood clotting disorders returned normal.
Treatment began with anticoagulation therapy using enoxaparin, coupled with iron supplementation. While iron is typically known for helping with anemia, its specific effect on blood clot resolution in this case remains unclear. Our patient's initial treatments were expanded to include catheter-directed thrombolysis to dissolve the clot, followed by a procedure to relieve venous compression.
We observed significant success in reducing the thrombus burden and restoring blood flow post-stenting. However, we noted that the role of iron supplementation alone in treating the blood clot is ambiguous when combined with other therapies. Thus, while iron is essential for overall health and could play a supportive role, its independent effectiveness against DVT is undetermined in this scenario.
Treatment began with anticoagulation therapy using enoxaparin, coupled with iron supplementation. While iron is typically known for helping with anemia, its specific effect on blood clot resolution in this case remains unclear. Our patient's initial treatments were expanded to include catheter-directed thrombolysis to dissolve the clot, followed by a procedure to relieve venous compression.
We observed significant success in reducing the thrombus burden and restoring blood flow post-stenting. However, we noted that the role of iron supplementation alone in treating the blood clot is ambiguous when combined with other therapies. Thus, while iron is essential for overall health and could play a supportive role, its independent effectiveness against DVT is undetermined in this scenario.
Read More
User Reviews
USERS' SCORE
Medium or Average
Based on 14 Reviews
6.5
- All Reviews
- Positive Reviews
- Negative Reviews
9
Symptoms alleviated
4 people found this helpful
I was identified with anaemia and began treatment recently. I noticed that dizziness from the anaemia has disappeared. I'm looking forward to my next blood test, as I feel significantly better overall.
Read More
9
Effective treatment
3 people found this helpful
This iron supplement literally saved me from needing a fourth blood transfusion. My levels were so low that my doctor suggested a transfusion. After taking two pills daily for three months, my hemoglobin rose from 8 to 12, and my iron from 15 to 40! There's no further proof required; it works!
Read More
9
Effective treatment
3 people found this helpful
Helped with anaemia. My spouse's blood test revealed a low haemoglobin of 79. Despite feeling well, the therapist didn’t believe it, but a retest confirmed the low level. After taking Sorbifer Durules for a month, we switched to Iron of the Sun based on positive reviews. We also added vitamin C. After 1.6 months, his haemoglobin rose to 144 without gastrointestinal side effects. It's rewarding to find an affordable and effective solution for health, which is paramount in life.
Read More
9
Health restored
3 people found this helpful
Taking this dietary supplement quickly normalised my menstrual cycle, and my blood pressure stabilised. I noticed significant improvements like better sleep and reduced headaches promptly after starting the treatment. No adverse side effects, and I am now feeling great!
Read More
9
Life-changing results
2 people found this helpful
My life changed when I started taking Gentle Iron for iron deficiency anaemia. I had severe symptoms, including lethargy and headaches. After starting this supplement, I felt better almost immediately and became productive again. My hemoglobin and ferritin levels normalized after two months of use; I even continue monitoring them with my doctor.
Read More
Frequently Asked Questions
7.5
Energised and better
1 people found this helpful
After a recent blood test revealing low hemoglobin of 100, I began taking "Gentle Iron." Within 15 days, my dizziness vanished, and I felt more energetic. My menstrual cycle also became less painful. I'll retest after my course, but for now, I'm very pleased with the results.
9
Effective treatment
3 people found this helpful
Helped with anaemia. My spouse's blood test revealed a low haemoglobin of 79. Despite feeling well, the therapist didn’t believe it, but a retest confirmed the low level. After taking Sorbifer Durules for a month, we switched to Iron of the Sun based on positive reviews. We also added vitamin C. After 1.6 months, his haemoglobin rose to 144 without gastrointestinal side effects. It's rewarding to find an affordable and effective solution for health, which is paramount in life.
2
Declined iron levels
5 people found this helpful
Unfortunately, after three months of taking this iron, my levels dropped from 128 to 93. I bought it based on positive reviews, but I’d suggest monitoring your blood tests closely. I ultimately returned to Fenuls as my treatment for blood clot.
2
Questionable effectiveness
5 people found this helpful
I had low haemoglobin, and the doctor recommended iron supplements. After two months of use, there was no increase in iron levels. I eventually had to resort to intramuscular injections, which did lead to a significant rise in my haemoglobin. This experience made me question the effectiveness of this iron supplement for treating blood clot.
9
Effective treatment
3 people found this helpful
This iron supplement literally saved me from needing a fourth blood transfusion. My levels were so low that my doctor suggested a transfusion. After taking two pills daily for three months, my hemoglobin rose from 8 to 12, and my iron from 15 to 40! There's no further proof required; it works!
9
Life-changing results
2 people found this helpful
My life changed when I started taking Gentle Iron for iron deficiency anaemia. I had severe symptoms, including lethargy and headaches. After starting this supplement, I felt better almost immediately and became productive again. My hemoglobin and ferritin levels normalized after two months of use; I even continue monitoring them with my doctor.
9
Health restored
3 people found this helpful
Taking this dietary supplement quickly normalised my menstrual cycle, and my blood pressure stabilised. I noticed significant improvements like better sleep and reduced headaches promptly after starting the treatment. No adverse side effects, and I am now feeling great!
2
No benefit observed
1 people found this helpful
This iron supplement didn’t help at all. Blood tests confirmed an iron deficiency, and I will not continue using it for this 90-year-old man with concerns about blood clot.
4
We explored a 50-year-old woman who came to us with noticeable swelling and pain in her left leg lasting ten days. Upon evaluation, we found that she had deep vein thrombosis (DVT) associated with May-Thurner Syndrome (MTS), where a vein is compressed by an artery. Initially, her blood tests showed normocytic anemia, yet the tests for blood clotting disorders returned normal.
Treatment began with anticoagulation therapy using enoxaparin, coupled with iron supplementation. While iron is typically known for helping with anemia, its specific effect on blood clot resolution in this case remains unclear. Our patient's initial treatments were expanded to include catheter-directed thrombolysis to dissolve the clot, followed by a procedure to relieve venous compression.
We observed significant success in reducing the thrombus burden and restoring blood flow post-stenting. However, we noted that the role of iron supplementation alone in treating the blood clot is ambiguous when combined with other therapies. Thus, while iron is essential for overall health and could play a supportive role, its independent effectiveness against DVT is undetermined in this scenario.
Treatment began with anticoagulation therapy using enoxaparin, coupled with iron supplementation. While iron is typically known for helping with anemia, its specific effect on blood clot resolution in this case remains unclear. Our patient's initial treatments were expanded to include catheter-directed thrombolysis to dissolve the clot, followed by a procedure to relieve venous compression.
We observed significant success in reducing the thrombus burden and restoring blood flow post-stenting. However, we noted that the role of iron supplementation alone in treating the blood clot is ambiguous when combined with other therapies. Thus, while iron is essential for overall health and could play a supportive role, its independent effectiveness against DVT is undetermined in this scenario.
9
ESA and iron enhance surgery outcomes
We aimed to understand how preoperative treatments like erythropoietin-stimulating agents (ESAs) and intravenous (IV) iron influence the risk of blood clots in surgical patients dealing with anaemia.
In our investigation, we found that patients who received ESAs—whether accompanied by IV iron or not—had lower risks of serious post-operative complications, including blood clots, compared to those who were given red blood cell transfusions. Specifically, those treated with ESAs without IV iron showed significant reductions in mortality and the occurrence of venous thromboembolic events.
Interestingly, when IV iron was combined with ESAs, it appeared to further enhance outcomes, notably improving survival rates. Our results suggest that combining these treatments might yield benefits for patients undergoing surgery, reflected in higher haemoglobin levels and fewer complications compared to traditional blood transfusions.
In our investigation, we found that patients who received ESAs—whether accompanied by IV iron or not—had lower risks of serious post-operative complications, including blood clots, compared to those who were given red blood cell transfusions. Specifically, those treated with ESAs without IV iron showed significant reductions in mortality and the occurrence of venous thromboembolic events.
Interestingly, when IV iron was combined with ESAs, it appeared to further enhance outcomes, notably improving survival rates. Our results suggest that combining these treatments might yield benefits for patients undergoing surgery, reflected in higher haemoglobin levels and fewer complications compared to traditional blood transfusions.
References
- Basu R, Reddy M, Kaabneh A, Mohamedelamin Khidir Ahmed A, Bamne S. May-Thurner Syndrome: An Unusual Case of Unilateral Severe Deep Vein Thrombosis in a Middle-Aged Women. Cureus. 2024;16:e75621. doi:10.7759/cureus.75621
- Choi UE, Nicholson RC, Frank SM, Cha S, Cho BC, et al. Use of preoperative erythropoietin-stimulating agents is associated with decreased thrombotic adverse events compared to red blood cell transfusion in surgical patients with anaemia. Vox Sang. 2024;119:1174. doi:10.1111/vox.13729
- Oliver AA, Carlson KD, Price C, Banaskiewicz K, Benike A, et al. Magnetic capture of blood outgrowth endothelial cells to the luminal surface of magnetizable stent-grafts promotes healing in a porcine pseudoaneurysm model. Acta Biomater. 2025. doi:10.1016/j.actbio.2025.03.040
